Log in to save to my catalogue

Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma

Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1069196776

Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma

About this item

Full title

Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma

Publisher

Vienna: Springer Vienna

Journal title

Acta neurochirurgica, 2012-08, Vol.154 (8), p.1371-1378

Language

English

Formats

Publication information

Publisher

Vienna: Springer Vienna

More information

Scope and Contents

Contents

Background
Combining Gliadel wafers and radiochemotherapy with TMZ may carry the risk of increased adverse events (AE). We analyzed the efficacy and safety in patients with glioblastoma who underwent multimodal treatment with implantation of Gliadel wafers.
Methods
One hundred sixty-five consecutive patients with newly diagnosed (77 patien...

Alternative Titles

Full title

Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1069196776

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1069196776

Other Identifiers

ISSN

0001-6268,0942-0940

E-ISSN

0942-0940

DOI

10.1007/s00701-012-1413-2

How to access this item